| 臺大學術典藏 |
2020-05-27T03:38:24Z |
Clinical risk assessment rating and all-cause mortality in secondary mental healthcare: The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) Case Register
|
CHIA-YI WU; Chang C.-K.; Hayes R.D.; Broadbent M.; Hotopf M.; Stewart R. |
| 中山醫學大學 |
2020 |
Clinical risk factors and outcomes of massive ascites accumulation after discontinuation of peritoneal dialysis
|
Chen, CL; Chen, NC; Hsu, CY; Huang, CW; Lee, PT; Chou, KJ; Fang, HC; Chang, MS |
| 中山醫學大學 |
2020 |
Clinical risk factors and outcomes of massive ascites accumulation after discontinuation of peritoneal dialysis (vol 42, pg 1, 2020)
|
Chen, CL; Chen, NC; Hsu, CY; Huang, CW; Lee, PT; Chou, KJ; Fang, HC; Chang, MS |
| 中國醫藥大學 |
2005-02 |
Clinical Risk Factors of Radiation Pneumonitis after 3D Conformal Radiotherapy for Lung Cancer?
|
簡君儒(Chun-Ru Chien); 許雅娟(Hsu, Y.C.); 王耀慶(Wang, Y.C.); 丁禮莉(Ding, L.L.)* |
| 臺大學術典藏 |
2020-07-31T11:24:35Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
HONG-YUAN HSU; MEI-HWEI CHANG; JIA-FENG WU; SHIANN-TARNG JOU; HUEY-LING CHEN; YEN-HSUAN NI; Hsu, Wei Yun; YUNG-LI YANG |
| 臺大學術典藏 |
2021-07-15T02:20:10Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Hsu W.-Y.; Chang H.-H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; HUEY-LING CHEN; Ni Y.-H.; Hsu H.-Y.; Chang M.-H.; Wu J.-F. |
| 臺大學術典藏 |
2020-12-16T07:21:43Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Yang Y.-L.; Jou S.-T.; Chen H.-L.; Ni Y.-H.; Hsu H.-Y.; Chang M.-H.; Wu J.-F.; Hsu W.-Y.; Chang H.-H.; MENG-YAO LU |
| 臺大學術典藏 |
2020 |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Chang M.-H.; Wu J.-F.; Hsu H.-Y.; Ni Y.-H.; Chen H.-L.; Jou S.-T.; Yang Y.-L.; Lu M.-Y.; HSIU-HAO CHANG; Hsu W.-Y. |
| 臺大學術典藏 |
2020-12-21T01:08:17Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
JIA-FENG WU; Chang M.-H.; Hsu H.-Y.; Hsu W.-Y.; Chang H.-H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; Chen H.-L.; Ni Y.-H. |
| 臺大學術典藏 |
2020 |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Chang H.-H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; Chen H.-L.; YEN-HSUAN NI; Hsu H.-Y.; Chang M.-H.; Wu J.-F.; Hsu W.-Y.;Chang H.-H.;Lu M.-Y.;Yang Y.-L.;Jou S.-T.;Chen H.-L.;Yen-Hsuan Ni;Hsu H.-Y.;Chang M.-H.;Wu J.-F.; Hsu W.-Y. |
| 臺大學術典藏 |
2021-01-04T07:32:08Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Hsu W.-Y.; Chang H.-H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; Chen H.-L.; Ni Y.-H.; Hsu H.-Y.; MEI-HWEI CHANG; Wu J.-F. |
| 臺大學術典藏 |
2021-01-05T02:28:42Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Chen H.-L.; SHIANN-TANG JOU; Yang Y.-L.; Lu M.-Y.; Chang H.-H.; Hsu W.-Y.; Ni Y.-H.; Hsu H.-Y.; Chang M.-H.; Wu J.-F. |
| 臺大學術典藏 |
2020 |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Hsu W.-Y.; Chang H.-H.; Lu M.-Y.; YUNG-LI YANG; Jou S.-T.; Chen H.-L.; Ni Y.-H.; Hsu H.-Y.; Chang M.-H.; Wu J.-F. |
| 臺大學術典藏 |
2021-06-04T05:55:59Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Hong-Yuan Hsu;Chang H.-H.;Lu M.-Y.;Yang Y.-L.;Jou S.-T.;Chen H.-L.;Ni Y.-H.;Hong-Yuan Hsu;Chang M.-H.;Wu J.-F.; HONG-YUAN HSU; Chang H.-H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; Chen H.-L.; Ni Y.-H.; HONG-YUAN HSU; Chang M.-H.; Wu J.-F. |
| 臺大學術典藏 |
2022-02-22T06:20:36Z |
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
|
Hsu, Wei-Yun; Chang, Hsiu-Hao; Lu, Meng-Yao; Yang, Yung-Li; Jou, Shiann-Tarng; Chen, Huey-Ling; Ni, Yen-Hsuan; HONG-YUAN HSU; Chang, Mei-Hwei; Wu, Jia-Feng |
| 南台科技大學 |
1998-03 |
Clinical Saccadic Stimulation Instrument
|
陳世中; Shih-Chung Chen; Ching-Hsing Luo |
| 中國醫藥大學 |
2011-10 |
Clinical Safety and Anticoagulation Efficacy of Low-Molecular-Weight in Chronic Hemodialysis Patients: A Single Medical Center Experience
|
莊峰榮(Feng-Rong Chuang);陳德全(Te-Chuan Chen);李志雄(Chih-Hsiung Lee);黃惠勇(Hwee-Yeong Huang);王怡寬(I-Kuan Wang);張學文(Hsueh-Wen Chang);莊博翔(Po-Hsiang Chuang);吳建興(Chien-Hsing Wu);楊智超(Chih-Chao Yang);蘇鈺壬 |
| 國立臺北護理健康大學 |
2020 |
Clinical Scenario Based Learning Appling to the Curriculum of Palliative Care in Long- Term Care: An Action Research and Effectiveness Evaluation
|
黃秀梨 |
| 亞洲大學 |
2015/07 |
CLINICAL SCIENCE
|
;Tang, 湯智昕 Chih-Hsin |
| 國立成功大學 |
2007-02 |
Clinical significance and distribution of putative virulence markers of 116 consecutive clinical Aeromonas isolates in southern Taiwan
|
Wu, Chi-Jung; Wu, Jiunn-Jong; Yan, Jing-Jou; Lee, Hsin-Chun; Lee, Nan-Yao; Chang, Chia-Ming; Shih, Hsin-I; Wu, Hsiu-Mei; Wang, Li-Rong; Ko, Wen-Chien |
| 國立臺灣大學 |
2014 |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su, Tung-Hung; Liu, Chun-Jen; Yang, Hung-Chih; Jeng, Yung-Ming; Cheng, Huei-Ru; Liu, Chen-Hua; Tseng, Tai-Chung; Ling, Thai-Yen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 林泰元; 高嘉宏; 鄭永銘; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 臺大學術典藏 |
2020-03-06T08:25:07Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su T.-H.; Liu C.-J.; Yang H.-C.; YUNG-MING JENG; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:39Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; CHEN-HUA LIU; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:11Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:43Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su T.-H.; CHUN-JEN LIU; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
